We like the company, and like its assets, and like the opportunities in front of it.

It's a large capitalization company and these sorts of volumes in a large cap don't come along often. It was extremely well marketed to big players who wanted volume in a large IPO.

Macquarie may have to raise the offer. It's a question of what shareholders want.

The Australian private health-care market is attractive for anybody wanting to come in and buy market share.

The issue of smoking bans and taxes have been around for a while and now the company is confirming its impact on profit.

Ricky's a cool, calm quarterback and he's not going to worry about the pressure.

Turnovers don't always happen when the ball hits the ground, sometimes it's just a matter of getting the other team's offence off the field.

We see the participants in the Australian health care market continuing to do very strongly.

Cochlear has world-class technology and with the new management in there they are delivering on that potential. The turnaround under Chris Roberts has been very strong.